Institutional Investors Eye Cannabis as Schedule III Move Nears
Federal marijuana rescheduling is opening the door for institutional investors to enter cannabis markets, but industry maturation and improv...
Federal marijuana rescheduling is opening the door for institutional investors to enter cannabis markets, but industry maturation and improv...
Federal officials and anti-cannabis groups filed a joint briefing schedule in the lawsuit challenging Trump's marijuana rescheduling, settin...
Washington cannabis regulators approved rule changes to help licensed operators comply with federal marijuana rescheduling to Schedule III, ...
The DEA opened a new Form 225 registration portal for state-licensed medical cannabis manufacturers, distributors, and labs seeking federal ...
A DEA administrative law judge has paused the federal cannabis rescheduling hearing to consider adding a GAO report that found the DEA and F...
Legislation
DEA's chief administrative law judge halted cannabis rescheduling proceedings to review a GAO report showing the agency aligned with HHS in ...
Legislation
Alabama health officials withdrew their objection to rescheduling marijuana at the state level, aligning with federal moves to reclassify ca...
Legislation
Alabama's health department has withdrawn its opposition to federal marijuana rescheduling after legal staff resolved initial concerns about...
Legislation
Ryan Dominguez leads the campaign to defeat Massachusetts Question 4, which would repeal adult-use cannabis. Industry leaders say the 2026 v...
Culture
A 1969 student magazine predicted that opponents would spend decades demanding more cannabis research to block reform. The DEA made the same...
Legislation
A federal court denied an injunction seeking to block Trump's cannabis rescheduling order, allowing the process to continue while legal chal...
Legislation
A federal appeals court rejected attempts by a drug testing association and pharma company to halt cannabis rescheduling, clearing the way f...